Kumar Neil (CIK 1742485) reported 173 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-20). Recent activity: Sell BBIO (1,900 shares), Sell BBIO (17,279 shares), Sell BBIO (14,602 shares), Sell BBIO (1,199 shares), Sell BBIO (8,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,900 | $154,184 |
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 17,279 | $1.4M |
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 14,602 | $1.2M |
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,199 | $100,444 |
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,100 | $679,256 |
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,800 | $152,436 |
| 2026-08-20 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 100 | $8,565 |
| 2026-08-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 11,554 | $0 |
| 2026-08-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 19,599 | $0 |
| 2026-08-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 33,544 | $0 |
| 2026-08-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Buy | 6,520 | $0 |
| 2026-08-18 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 36,237 | $2.9M |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,437 | $572,744 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,429 | $95,347 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 15,921 | $1.1M |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 450 | $30,721 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 2,200 | $144,584 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 1,429 | $95,347 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 15,921 | $1.1M |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 450 | $30,721 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 7,147 | $480,271 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 8,437 | $572,744 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 4,416 | $304,524 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 7,148 | $480,338 |
| 2026-06-08 | BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer | Sell | 2,200 | $144,584 |
Source: SEC Form 4 filings · as of 2026-08-20